{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:23:12Z","timestamp":1791256992784,"version":"4.1.0"},"reference-count":132,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The proliferation and sustained detection of novel psychoactive benzodiazepines in forensic and clinical toxicology, combined with their potential for adverse events, poses an enduring threat to public health and safety with complex characteristics and challenges unique from other subclasses of novel psychoactive substances (NPS). This study aimed to systematically review the published effects, observations, and toxicological data from postmortem and human performance studies [including clinical, driving under the influence of drugs (DUID), and drug-facilitated crimes (DFC)] involving NPS benzodiazepines from 2021 to 2025. The challenges this class of compounds presents to clinicians, toxicologists, and medical professionals were also addressed, including both analytical and interpretative challenges. Literature reviews were performed in PubMed, Google Scholar, Google Search, toxicology journals, and conference abstract proceedings using search terms such as \u201cNPS benzodiazepines,\u201d \u201cdesigner benzodiazepines,\u201d and compound specific searches; authoritative websites such as NPS Discovery, National Forensic Laboratory Information System, and the European Union Drug Agency were also consulted. A total of 259 NPS benzodiazepine-related studies were identified including 29 postmortem, 15 DUID, 27 clinical, and 5 DFC studies detailed in this review. NPS benzodiazepines were widely pervasive in both postmortem and human performance cases with overlapping toxic and recreational concentrations; often involving polysubstance use with other central nervous system depressants and stimulants. Unique clinical presentations, observed effects, and autopsy findings were also reported for NPS benzodiazepines. This review provides an updated, consolidated resource to support toxicologists and clinicians in interpretation, emerging risk assessment, and evolving challenges associated with NPS benzodiazepines across postmortem and human performance settings.<\/jats:p>","DOI":"10.1093\/jat\/bkag026","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:49:10Z","timestamp":1776858550000},"source":"Crossref","is-referenced-by-count":1,"title":["An enduring threat: NPS benzodiazepines in forensic and clinical toxicology from 2021 to 2025"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6283-5820","authenticated-orcid":false,"given":"Kayla N","family":"Ellefsen","sequence":"first","affiliation":[{"name":"Travis County Medical Examiner , Austin, TX 78724,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-9753","authenticated-orcid":false,"given":"Erin L","family":"Karschner","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , Dover AFB, DE 19902,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-2421","authenticated-orcid":false,"given":"Sandrine A M","family":"M\u00e9rette","sequence":"additional","affiliation":[{"name":"Provincial Toxicology Centre, Provincial Health Services Authority , Vancouver, BC V5H 4R4,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-8770","authenticated-orcid":false,"given":"Amy L","family":"Patton","sequence":"additional","affiliation":[{"name":"North Louisiana Criminalistics Laboratory , Shreveport, LA 71103,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa N","family":"Shoff","sequence":"additional","affiliation":[{"name":"Miami-Dade Medical Examiner Department , Miami, FL 33136,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R","family":"Smith","sequence":"additional","affiliation":[{"name":"Travis County Medical Examiner , Austin, TX 78724,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-5379","authenticated-orcid":false,"given":"Michael T","family":"Truver","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani C","family":"Mata","sequence":"additional","affiliation":[{"name":"Toxicology Section, Houston Forensic Science Center , Houston, TX 77002,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-3259","authenticated-orcid":false,"given":"Donna M","family":"Papsun","sequence":"additional","affiliation":[{"name":"NMS Labs , Horsham, PA 19044","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"2026060806314064100_bkag026-B1","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/molecules28134969","article-title":"Understanding the mechanisms of action and effects of drugs of abuse","volume":"28","author":"Ciuc\u0103 Anghel","year":"2023","journal-title":"Molecules"},{"key":"2026060806314064100_bkag026-B2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/10408444.2021.1907303","article-title":"Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step?","volume":"51","author":"Moustafa","year":"2021","journal-title":"Crit Rev Toxicol"},{"key":"2026060806314064100_bkag026-B3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11419-022-00616-y","article-title":"The blood-to-plasma ratio and predicted GABAA-binding affinity of designer benzodiazepines","volume":"40","author":"Manchester","year":"2022","journal-title":"Forensic Toxicol"},{"key":"2026060806314064100_bkag026-B4","author":"Drug Enforcement Administration","year":"2025"},{"key":"2026060806314064100_bkag026-B5","author":"Drug Enforcement Administration","year":"2020"},{"key":"2026060806314064100_bkag026-B6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s40120-024-00628-3","article-title":"Fake Xanax: designer emerging benzodiazepine epidemic linked to morbidity and mortality a narrative review","volume":"13","author":"Kaye","year":"2024","journal-title":"Neurol Ther"},{"key":"2026060806314064100_bkag026-B7","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00414-020-02352-7","article-title":"The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine","volume":"134","author":"Kolbe","year":"2020","journal-title":"Int J Legal Med"},{"key":"2026060806314064100_bkag026-B8","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1111\/add.70174","article-title":"Counterfeit \u2018Xanax\u00ae\u2019 tablets: a comparative study of clinical and seizure data in Victoria, Australia","volume":"120","author":"Syrjanen","year":"2025","journal-title":"Addiction"},{"key":"2026060806314064100_bkag026-B9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/dta.3119","article-title":"What\u2019s in fake \u2018Xanax\u2019?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets","volume":"14","author":"Blakey","year":"2022","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jat\/bkae027","article-title":"Suspected North Carolina counterfeit pill-involved deaths, 2020-2022","volume":"48","author":"Friederich","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/dar.14068","article-title":"Contents and time-course of falsified alprazolam detections in New South Wales, Australia","volume":"44","author":"Smith","year":"2025","journal-title":"Drug Alcohol Rev"},{"key":"2026060806314064100_bkag026-B12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.15585\/mmwr.mm725253a5","article-title":"Notes from the field: seizures, hyperthermia, and myocardial injury in three young adults who consumed bromazolam disguised as alprazolam\u2014Chicago, Illinois, February 2023","volume":"72","author":"Ehlers","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026060806314064100_bkag026-B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clinbiochem.2022.11.003","article-title":"Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply","volume":"111","author":"Delaney","year":"2023","journal-title":"Clin Biochem"},{"key":"2026060806314064100_bkag026-B14","doi-asserted-by":"publisher","first-page":"104751","DOI":"10.1016\/j.drugpo.2025.104751","article-title":"Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada","volume":"138","author":"Gonzalez-Nieto","year":"2025","journal-title":"Int J Drug Policy"},{"key":"2026060806314064100_bkag026-B15","doi-asserted-by":"publisher","first-page":"111777","DOI":"10.1016\/j.forsciint.2023.111777","article-title":"Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope\/ fentanyl toxicity cases in Alberta, Canada","volume":"350","author":"Chatterton","year":"2023","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B16","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.fsisyn.2021.100138","article-title":"Benzodiazepines reported in NFLIS-Drug, 2015 to 2018","volume":"3","author":"Bollinger","year":"2021","journal-title":"Forensic Sci Int Synerg"},{"key":"2026060806314064100_bkag026-B17","volume-title":"New Benzodiazepines in Europe\u2014A Review","author":"European Union Drug Agency (EUDA)","year":"2021"},{"key":"2026060806314064100_bkag026-B18","first-page":"1","author":"Advisory Council of the Misuse of Drugs","year":"2024"},{"key":"2026060806314064100_bkag026-B19","first-page":"1","author":"Krotulski","year":"2022"},{"key":"2026060806314064100_bkag026-B20","first-page":"1","author":"Krotulski","year":"2022"},{"key":"2026060806314064100_bkag026-B21","first-page":"1","author":"Krotulski","year":"2023"},{"key":"2026060806314064100_bkag026-B22","first-page":"1","author":"Krotulski","year":"2023"},{"key":"2026060806314064100_bkag026-B23","first-page":"1","author":"Krotulski","year":"2022"},{"key":"2026060806314064100_bkag026-B24","first-page":"1","author":"Krotulski","year":"2020"},{"key":"2026060806314064100_bkag026-B25","author":"Krotulski","year":"2020"},{"key":"2026060806314064100_bkag026-B26","author":"United Nations Office on Drugs","year":"2020"},{"key":"2026060806314064100_bkag026-B27","doi-asserted-by":"publisher","first-page":"e1\u20132","DOI":"10.1093\/jat\/bkaa169","article-title":"Clarification of the Correct Nomenclature of the Amino Metabolite of Clonazolam: 8-Aminoclonazolam","volume":"45","author":"Maskell","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jat\/bkx031","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2013-2016: a review","volume":"41","author":"Logan","year":"2017","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B29","doi-asserted-by":"publisher","first-page":"e116\u201385","DOI":"10.1093\/jat\/bkac023","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2017\u20132020: a review","volume":"46","author":"Mohr","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/ph14060560","article-title":"Designer benzodiazepines: a review of toxicology and public health risks","volume":"14","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026060806314064100_bkag026-B31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"key":"2026060806314064100_bkag026-B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/0269881119901096","article-title":"Designer benzodiazepines\u2019 pharmacological effects and potencies: How to find the information","volume":"34","author":"El Balkhi","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2026060806314064100_bkag026-B34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2478\/aiht-2023-74-3771","article-title":"Recent findings and advancements in the detection of designer benzodiazepines: a brief review","volume":"74","author":"Wu","year":"2022","journal-title":"Arh Hig Rada Toksikol"},{"key":"2026060806314064100_bkag026-B35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/jat\/bkae098","article-title":"Advances in analytical methodologies for detecting novel psychoactive substances: a review","volume":"49","author":"Krotulski","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/17512433.2023.2170349","article-title":"Designer benzodiazepines: an update","volume":"16","author":"Yu","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2026060806314064100_bkag026-B37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in post-mortem cases\u2014a British Columbia perspective","volume":"47","author":"M\u00e9rette","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/jat\/bkae053","article-title":"Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023)","volume":"48","author":"Shanks","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/jat\/bkae067","article-title":"The emergence of bromazolam in Jefferson County, AL: a case series","volume":"48","author":"Green","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jat\/bkae079","article-title":"The rise of bromazolam in postmortem cases from Travis County, TX, and surrounding areas: 2021 to 2023","volume":"49","author":"Ellefsen","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/jat\/bkae082","article-title":"Double designers: detection of bromazolam and metonitazene in postmortem casework","volume":"49","author":"Van Cleve","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B42","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/1556-4029.70003","article-title":"Identifying bromazolam, etizolam, and flualprazolam in blood using gas chromatography-mass spectrometry","volume":"70","author":"Ballotari","year":"2025","journal-title":"J Forensic Sci"},{"key":"2026060806314064100_bkag026-B43","doi-asserted-by":"publisher","first-page":"111891","DOI":"10.1016\/j.forsciint.2023.111891","article-title":"Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales","volume":"354","author":"Hikin","year":"2024","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/PAF.0000000000000992","article-title":"Desalkylgidazepam","volume":"45","author":"Hargrove","year":"2024","journal-title":"Am J Forensic Med Pathol"},{"key":"2026060806314064100_bkag026-B45","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/add.16520","article-title":"The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco","volume":"119","author":"Rodda","year":"2024","journal-title":"Addiction"},{"key":"2026060806314064100_bkag026-B46","doi-asserted-by":"publisher","first-page":"e285\u201390","DOI":"10.1093\/jat\/bkac098","article-title":"A fatal case report resulting from the abuse of the designer benzodiazepines clonazolam and flualprazolam in conjunction with dried opium poppy pods\u2021","volume":"46","author":"Theofel","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/PAF.0000000000000803","article-title":"Clonazolam intoxication case report: danger of designer benzodiazepines","volume":"43","author":"Moore","year":"2022","journal-title":"Am J Forensic Med Pathol"},{"key":"2026060806314064100_bkag026-B48","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/dta.3115","article-title":"Metonitazene in the United States-Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry","volume":"13","author":"Krotulski","year":"2021","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B49","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/jat\/bkad072","article-title":"Desalkylgidazepam blood concentrations in 63 forensic investigation cases","volume":"47","author":"M\u00e9rette","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B50","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/jat\/bkaa146","article-title":"A case series of etizolam in opioid-related deaths","volume":"45","author":"Gevorkyan","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/0025802420973814","article-title":"Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases","volume":"61","author":"Hikin","year":"2021","journal-title":"Med Sci Law"},{"key":"2026060806314064100_bkag026-B52","doi-asserted-by":"publisher","first-page":"112438","DOI":"10.1016\/j.forsciint.2025.112438","article-title":"Postmortem distribution of etizolam in various autopsy samples using the surrogate analyte approach (SAA) method","volume":"370","author":"Yuyama","year":"2025","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B53","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/jat\/bkae075","article-title":"Deaths involving novel benzodiazepines in Victoria, Australia from 2018 to 2022","volume":"48","author":"Drummer","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/1556-4029.14893","article-title":"Flualprazolam distribution in postmortem samples","volume":"67","author":"Ha","year":"2022","journal-title":"J Forensic Sci"},{"key":"2026060806314064100_bkag026-B55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jat\/bkaa070","article-title":"Flualprazolam blood concentrations in 197 forensic investigation Cases","volume":"45","author":"Papsun","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jat\/bkaa098","article-title":"Quantification of flualprazolam in blood by LC\u2013MS-MS: a case series of nine deaths","volume":"45","author":"Rice","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11419-021-00591-w","article-title":"A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues","volume":"40","author":"Giorgetti","year":"2022","journal-title":"Forensic Toxicol"},{"key":"2026060806314064100_bkag026-B58","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/jat\/bkad058","article-title":"Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada","volume":"47","author":"Vekic","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B59","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00414-024-03263-7","article-title":"Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities","volume":"138","author":"Giorgetti","year":"2024","journal-title":"Int J Legal Med"},{"key":"2026060806314064100_bkag026-B60","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/jat\/bkad041","article-title":"Rilmazafone: a designer benzodiazepine pro-drug involved in fatal intoxications","volume":"47","author":"Kronstrand","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B61","author":"Krotulski","year":"2020"},{"key":"2026060806314064100_bkag026-B62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/biology12020273","article-title":"New psychoactive substances intoxications and fatalities during the COVID-19 epidemic","volume":"12","author":"Lo Faro","year":"2023","journal-title":"Biology (Basel)"},{"key":"2026060806314064100_bkag026-B63","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jat\/bkae059","article-title":"A postmortem case report involving fentanyl, desalkylgidazepam, and bromazolam","volume":"48","author":"Ballotari","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B64","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/15563650.2025.2524078","article-title":"Clinical characterisation of the novel benzodiazepine bromazolam-data from the ASSIST (A Surveillance Study of Illicit Substance Toxicity) study","volume":"63","author":"Dunlop","year":"2025","journal-title":"Clin Toxicol (Phila)"},{"key":"2026060806314064100_bkag026-B65","doi-asserted-by":"publisher","first-page":"112776","DOI":"10.1016\/j.drugalcdep.2025.112776","article-title":"Detected substances among patients with confirmed bromazolam exposure who present to the emergency department following a suspected opioid and\/or stimulant-related non-fatal overdose","volume":"274","author":"Falise","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"2026060806314064100_bkag026-B66","doi-asserted-by":"publisher","first-page":"e70104","DOI":"10.1111\/acem.70104","article-title":"Benzodiazepine co-exposure among patients presenting to the emergency department with a confirmed opioid overdose","volume":"33","author":"Hughes","year":"2026","journal-title":"Acad Emerg Med"},{"key":"2026060806314064100_bkag026-B67","doi-asserted-by":"publisher","first-page":"104969","DOI":"10.1016\/j.drugpo.2025.104969","article-title":"Novel psychoactive substances in Australian emergency departments: implications for public health practice from multi-centre prospective toxicosurveillance across five states, 2022-2023","volume":"145","author":"Smith","year":"2025","journal-title":"Int J Drug Policy"},{"key":"2026060806314064100_bkag026-B68","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jat\/bkae012","article-title":"Identification of clobromazolam in Australian emergency department intoxications using data-independent high-resolution mass spectrometry and the HighResNPS.com database","volume":"48","author":"Castle","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13181-024-01051-8","article-title":"Comparison of laboratory confirmed drugs in acute recreational drug toxicity presentations to an Urban Hospital in London, UK, 2016\/17 versus 2019\/20","volume":"21","author":"Wolfe","year":"2025","journal-title":"J Med Toxicol"},{"key":"2026060806314064100_bkag026-B70","doi-asserted-by":"publisher","first-page":"104245","DOI":"10.1016\/j.drugpo.2023.104245","article-title":"Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia\u2014Victoria project 2020-2022","volume":"122","author":"Syrjanen","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2026060806314064100_bkag026-B71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/bcpt.13786","article-title":"Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis","volume":"131","author":"Axelsson","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026060806314064100_bkag026-B72","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.15585\/mmwr.mm7034a4","article-title":"Notes from the field: illicit benzodiazepines detected in patients evaluated in emergency departments for suspected opioid overdose\u2014Four States, October 6, 2020-March 9, 2021","volume":"70","author":"Aldy","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026060806314064100_bkag026-B73","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/15563650.2025.2490831","article-title":"Occult bromazolam exposure in patients presenting with opioid or stimulant overdose","volume":"63","author":"Cembellin-Kao","year":"2025","journal-title":"Clin Toxicol (Phila)"},{"key":"2026060806314064100_bkag026-B74","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/10550887.2024.2365006","article-title":"Clinical detoxification of bromazolam using diazepam: a case report","volume":"43","author":"Buitenhuis","year":"2025","journal-title":"J Addict Dis"},{"key":"2026060806314064100_bkag026-B75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13181-023-00930-w","article-title":"Acute opioid overdose following nasal atomization of a novel designer opioid, 2-methyl AP-237, with potentiation of designer benzodiazepines, pyrazolam and clonazolam. 2023 ACNT Annual Scientific Meeting Abstracts\u2014San Diego, CA","volume":"19","author":"Dash","year":"2023","journal-title":"J Med Toxicol"},{"key":"2026060806314064100_bkag026-B76","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/jat\/bkaa161","article-title":"Flubromazolam-derived designer benzodiazepines: toxicokinetics and analytical toxicology of clobromazolam and bromazolam","volume":"45","author":"Wagmann","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B77","author":"Papsun"},{"key":"2026060806314064100_bkag026-B78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/1742-6723.14108","article-title":"From signal to alert: A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines","volume":"35","author":"Syrjanen","year":"2023","journal-title":"Emerg Med Australas"},{"key":"2026060806314064100_bkag026-B79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/15563650.2023.2183105","article-title":"Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia\u2014Victoria project","volume":"61","author":"Syrjanen","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"2026060806314064100_bkag026-B80","first-page":"93","article-title":"Clonazolam, a designer benzodiazepine, presents unique challenges in withdrawal compared to traditional benzodiazepines. 2022 ACMT Annual Scientific Meeting Abstracts\u2014Virtual","volume":"17","author":"Dion","year":"2021","journal-title":"J. Med. Toxicol"},{"key":"2026060806314064100_bkag026-B81","doi-asserted-by":"publisher","first-page":"111324","DOI":"10.1016\/j.forsciint.2022.111324","article-title":"Toxicity of designer benzodiazepines: a case of etizolam and cocaine intoxication","volume":"336","author":"Drevin","year":"2022","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B82","first-page":"75","article-title":"Novel benzodiazepine ingestion associated with sinus bradycardia and premature ventricular contraction (PVC) in overdose. 2022 ACMT Annual Scientific Meeting Abstracts\u2014Virtual","volume":"18","author":"Royalty","year":"2022","journal-title":"J Med Toxicol"},{"key":"2026060806314064100_bkag026-B83","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1097\/ADM.0000000000000857","article-title":"Outpatient treatment of chronic designer benzodiazepine use: a case report","volume":"16","author":"Hauck","year":"2022","journal-title":"J Addict Med"},{"key":"2026060806314064100_bkag026-B84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13181-021-00832-9","article-title":"Flumazenil continuous infusion to treat novel liquid benzodiazepine flubromazolam intoxication. 2021 ACMT Annual Scientific Meeting Abstracts\u2014Virtual","volume":"17","author":"Hou","year":"2021","journal-title":"J Med Toxicol"},{"key":"2026060806314064100_bkag026-B85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/15563650.2021.1931692","article-title":"Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom","volume":"60","author":"Haden","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"2026060806314064100_bkag026-B86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13181-021-00832-9","article-title":"Pyrazolam ingestion leading to profound CNS depression. 2021 ACMT Annual Scientific Meeting Abstracts\u2014Virtual","volume":"17","author":"Trautman","year":"2021","journal-title":"J Med Toxicol"},{"key":"2026060806314064100_bkag026-B87","author":"Yeh","year":"2021"},{"key":"2026060806314064100_bkag026-B88","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11419-025-00750-3","article-title":"An unusual way of acute Pyrazolam poisoning in consumer of commercially approved benzodiazepines","volume":"44","author":"Magny","year":"2026","journal-title":"Forensic Toxicol"},{"key":"2026060806314064100_bkag026-B89","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jat\/bkad036","article-title":"Increasing prevalence of designer benzodiazepines in impaired driving: a 5-year analysis from 2017 to 2021","volume":"47","author":"Papsun","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B90","doi-asserted-by":"publisher","first-page":"e280\u20134","DOI":"10.1093\/jat\/bkac071","article-title":"Combined use of flubromazepam and stimulants: blood and oral fluid concentrations and impact on driving ability","volume":"46","author":"Wille","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B91","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jat\/bkad047","article-title":"Interference of the novel designer benzodiazepine 4\u02b9-chloro deschloroalprazolam with alprazolam analysis in toxicology and seized drug DUID casework","volume":"47","author":"Reber","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B92","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1093\/jat\/bkac019","article-title":"Driving impairment cases involving flualprazolam","volume":"46","author":"Youso","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B93","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jat\/bkab106","article-title":"Etizolam blood concentrations in 191 forensic cases in Ontario, Canada (2019\u20132020)","volume":"46","author":"Watts","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B94","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/jat\/bkac012","article-title":"A two-year evaluation of flualprazolam concentrations in orange county drivers: effects on driving and field sobriety test performance","volume":"46","author":"Manaloto","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B95","doi-asserted-by":"publisher","first-page":"e78\u201381","DOI":"10.1093\/jat\/bkab105","article-title":"Driving under the influence of flualprazolam: 10 case reports","volume":"46","author":"Mercurio","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B96","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/jat\/bkae074","article-title":"Bromazolam in impaired driving investigations","volume":"48","author":"Bierly","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B97","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/jat\/bkaa109","article-title":"Novel and nonroutine benzodiazepines and suvorexant by LC\u2013MS-MS","volume":"45","author":"Garcia","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B98","doi-asserted-by":"publisher","first-page":"111207","DOI":"10.1016\/j.forsciint.2022.111207","article-title":"The incidence of psychoactive substances and alcohol among impaired drivers in Denmark in 2015-2019","volume":"333","author":"Simonsen","year":"2022","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B99","author":"Tiscione"},{"key":"2026060806314064100_bkag026-B100","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jat\/bkae017","article-title":"Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA)","volume":"48","author":"Cieri","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B101","author":"Mai"},{"key":"2026060806314064100_bkag026-B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkac017","article-title":"The evolution towards designer benzodiazepines in drug-facilitated sexual assault cases","volume":"47","author":"Perez Orts","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.forsciint.2019.02.039","article-title":"A retrospective analysis of data from forensic toxicology at the Academy of Forensic Science in 2017","volume":"298","author":"Pan","year":"2019","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B104","doi-asserted-by":"publisher","first-page":"110595","DOI":"10.1016\/j.forsciint.2020.110595","article-title":"A comprehensive analytical process, from NPS threat identification to systematic screening: method validation and one-year prevalence study","volume":"318","author":"Garneau","year":"2021","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.forsciint.2018.08.034","article-title":"A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases","volume":"292","author":"Grela","year":"2018","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B106","first-page":"30","article-title":"To drop or not to drop: an NPS question","volume":"46","author":"Papsun","year":"2022","journal-title":"ToxTalk"},{"key":"2026060806314064100_bkag026-B107","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/1556-4029.15556","article-title":"Seized drug reporting of NPS helps to guide regional toxicological practice: a 17\u2009month review between 2022 and 2023","volume":"69","author":"Ellefsen","year":"2024","journal-title":"J Forensic Sci"},{"key":"2026060806314064100_bkag026-B108","first-page":"1","author":"Krotulski","year":"2025"},{"key":"2026060806314064100_bkag026-B109","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/jat\/bkab110","article-title":"Determination of cross-reactivity of novel psychoactive substances with drug screen immunoassays kits in whole blood","volume":"46","author":"Mastrovito","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B110","first-page":"31","article-title":"The increasing scope of designer benzodiazepines: details on 4\u2019-chloro deschloroalprazolam and clonazolam","volume":"46","author":"Ellefsen","year":"2022","journal-title":"ToxTalk"},{"key":"2026060806314064100_bkag026-B111","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/dta.3325","article-title":"The alprazolam analogue 4\u2019-chloro deschloroalprazolam identified in seized capsules","volume":"14","author":"Trigg","year":"2022","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B112","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2174\/1570159X18666200110121333","article-title":"\u2018New\/designer benzodiazepines\u2019: an analysis of the literature and psychonauts\u2019 trip reports","volume":"18","author":"Orsolini","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"2026060806314064100_bkag026-B113","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/jat\/bkae069","article-title":"Elucidating the potential role of microorganisms in postmortem biotransformation: a comparison of clonazolam and its metabolite in postmortem and DUID cases","volume":"48","author":"Casey","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B114","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/dta.2243","article-title":"Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography\u2013high resolution mass spectrometry","volume":"10","author":"Bergstrand","year":"2018","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B115","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B116","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00414-025-03627-7","article-title":"Fatal intoxication involving amphetamine, clonazafone, a benzodiazepine prodrug, and fluoro-etonitazene, a new synthetic opioid","volume":"140","author":"Malzacher","year":"2026","journal-title":"Int J Legal Med"},{"key":"2026060806314064100_bkag026-B117","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/jat\/bkad004","article-title":"Designer benzodiazepines gidazepam and desalkygidazepam (bromonordiazepam): what do we know?","volume":"47","author":"Maskell","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B118","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/dta.3150","article-title":"Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13-year retrospective study","volume":"14","author":"Niebel","year":"2022","journal-title":"Drug Test Anal"},{"key":"2026060806314064100_bkag026-B119","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/jat\/bkz048","article-title":"Oral fluid drug testing: analytical approaches, issues and interpretation of results","volume":"43","author":"Desrosiers","year":"2019","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B120","author":"Taruvinga"},{"key":"2026060806314064100_bkag026-B121","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5811\/cpcem.59853","article-title":"Intentional overdose on liquid clonazolam reversed with flumazenil: a case report","volume":"7","author":"Galletta","year":"2023","journal-title":"Clin Pract Cases Emerg Med"},{"key":"2026060806314064100_bkag026-B122","doi-asserted-by":"publisher","first-page":"e50741","DOI":"10.7759\/cureus.50741","article-title":"Rhabdomyolysis in the context of designer benzodiazepine misuse","volume":"15","author":"Noe","year":"2023","journal-title":"Cureus"},{"key":"2026060806314064100_bkag026-B123","doi-asserted-by":"publisher","first-page":"109244","DOI":"10.1016\/j.drugalcdep.2021.109244","article-title":"Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020","volume":"231","author":"Essink","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"2026060806314064100_bkag026-B124","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jaclp.2022.08.010","article-title":"Designer benzodiazepine use in pregnancy: a case report","volume":"64","author":"Buckley","year":"2023","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"2026060806314064100_bkag026-B125","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/10550887.2022.2117510","article-title":"Designer benzodiazepine dependence and the difficulties of outpatient management; a case report","volume":"42","author":"Reeves","year":"2024","journal-title":"J Addict Dis"},{"key":"2026060806314064100_bkag026-B126","doi-asserted-by":"publisher","first-page":"111140","DOI":"10.1016\/jforsciint.2021.111140","article-title":"Characteristics of fatal \u2018novel\u2019 benzodiazepine toxicity in Australia","volume":"331","author":"Darke","year":"2022","journal-title":"Forensic Sci Int"},{"key":"2026060806314064100_bkag026-B127","doi-asserted-by":"publisher","first-page":"e0310655","DOI":"10.1371\/journal.pone.0310655","article-title":"Systematic review: the relationship between gabapentinoids, etizolam, and drug related deaths in Scotland","volume":"19","author":"Ciesluk","year":"2024","journal-title":"PLoS One"},{"key":"2026060806314064100_bkag026-B128","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jat\/bkaa043","article-title":"Blood concentrations of designer benzodiazepines: relation to impairment and findings in forensic cases","volume":"44","author":"Heide","year":"2020","journal-title":"J Anal Toxicol"},{"key":"2026060806314064100_bkag026-B129","doi-asserted-by":"publisher","first-page":"103169","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2026060806314064100_bkag026-B130","doi-asserted-by":"publisher","first-page":"e14512","DOI":"10.1111\/1742-6723.14512","article-title":"A cluster of multi-drug intoxications involving xylazine, benzimidazole opioids (nitazenes) and novel benzodiazepines in South Australia","volume":"37","author":"Partridge","year":"2025","journal-title":"Emerg Med Australas"},{"key":"2026060806314064100_bkag026-B131","author":"Papsun","year":"2022"},{"key":"2026060806314064100_bkag026-B132","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/1556-4029.15283","article-title":"Emergence of fentanyl-related deaths in Travis County, Texas and surrounding areas: A retrospective review of postmortem fentanyl-related drug toxicities from 2020 to 2022","volume":"68","author":"Ellefsen","year":"2023","journal-title":"J Forensic Sci"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag026\/68157458\/bkag026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/6\/bkag026\/68157458\/bkag026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/6\/bkag026\/68157458\/bkag026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:31:54Z","timestamp":1780914714000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag026\/8662327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag026","relation":{},"ISSN":["1945-2403"],"issn-type":[{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,24]]},"article-number":"bkag026"}}